Rosty Raykov, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 10,000 shares at $6.08 ($61K) on 2025-01-06, disclosed to the SEC on 2025-01-07.
Scheduled sale ($61k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.08 | 2,431 | $15K | 24.3% |
| 2 | $6.08 | 7,569 | $46K | 75.7% |
| Total | $6.08 avg | 10,000 | $61K | 100% |
| Filing → |
| FENC | SELL | 2026-07-02 | $100K | — | Filing → |
| FENC | SELL | 2026-06-02 | $94K | — | Filing → |
| FENC | SELL | 2026-05-01 | $70K | — | Filing → |